Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2013
11/28/2013WO2012068531A3 Novel compositions and uses of anti-hypertension agents for cancer therapy
11/28/2013WO2002101078A8 Cellulases, nucleic acids encoding them and methods for making and using them
11/28/2013WO2002077260A8 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/28/2013US20130318644 Methods for treating disorders that involve immunoglobulin a
11/28/2013US20130318640 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives
11/28/2013US20130317569 Optogenetic Control of Reward-Related Behaviors
11/28/2013US20130317205 Conformationally Specific Viral Immunogens
11/28/2013US20130317085 Modulation of apolipoprotein c-iii expression
11/28/2013US20130317046 Use of a dpp-4 inhibitor in autoimmune diabetes, particularly lada
11/28/2013US20130316963 Innate defence regulatory peptide compositions for treatment of arthritis
11/28/2013US20130316961 Treatment of mecp-2 associated disorders
11/28/2013US20130316955 Aminostatin derivatives for the treatment of arthrosis
11/28/2013US20130316954 Methods of Treating Depression and Other Related Diseases
11/28/2013US20130316953 New uses for amino acid anticonvulsants
11/28/2013US20130316949 Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members
11/28/2013US20130316947 Therapeutic use of scgb3a2
11/28/2013US20130316946 Extended recombinant polypeptide-modified c-peptide
11/28/2013US20130316945 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/28/2013US20130316943 Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
11/28/2013US20130316941 Glucagon analogues
11/28/2013US20130316448 Peptides and related molecules that modulate nerve growth factor activity
11/28/2013US20130316354 Mammalian cytokine; related reagents
11/28/2013US20130316002 Compositions and methods for treating gastrointestinal motility dysfunction
11/28/2013US20130315997 Parenteral Composition Comprising Microspheres With a Diameter Between 10 And 20 Microns
11/28/2013US20130315996 Bio-functionalized stimulus-responsive dissolvable peg-hydrogels
11/28/2013US20130315986 Tumor-Specific Delivery of Therapeutic Agents Via Liposomase
11/28/2013US20130315984 Anti-trypanosomal peptides and uses thereof
11/28/2013US20130315961 Generation of novel bone forming cells (monoosteophils) from ll-37 treated monocytes
11/28/2013US20130315952 Administration of interferon for prophylaxis against or treatment of pathogenic infection
11/28/2013US20130315951 Compositions and methods for stimulating an immune response against infectious agents
11/28/2013US20130315949 Molecular Antigen Array
11/28/2013US20130315942 WDRPUH Epitope Peptides and Vaccines Containing the Same
11/28/2013US20130315926 Methods and materials for modulating resistance to apoptosis
11/28/2013US20130315924 Subdermal Tissue Remodeling Using Myostatin, Methods and Related Systems
11/28/2013US20130315922 Method for inducing lymphoid tissue and modulating intestinal homeostasis
11/28/2013US20130315897 Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa Inhibitor
11/28/2013US20130315891 Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
11/28/2013US20130315890 Extramuscular treatment of traumatic-induced migraine headache
11/28/2013US20130315863 Methods and compositions for treating flaviviridae infections
11/28/2013US20130315862 Methods and compositions for treating hepatitis c virus
11/28/2013US20130315859 Anti-inflammatory compositions
11/28/2013US20130315857 Kexin-Derived Vaccines to Prevent or Treat Fungal Infections
11/28/2013US20130315833 Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (cmr1)
11/28/2013US20130315828 Kit and method of use of targeting peptide for diagnosis and therapy of cancer
11/28/2013DE102012104530A1 Verwendung einer biokompatiblen Zusammensetzung Use of a biocompatible composition
11/28/2013CA2874258A1 Peptide and the use thereof
11/27/2013EP2666854A1 Recombinant elastase proteins and methods of manufacturing and use thereof
11/27/2013EP2666853A1 Modified phosphatases
11/27/2013EP2666783A2 Compositions and methods for inhibiting interleukin-23 pathways
11/27/2013EP2666476A1 Intraventricular enzyme delivery for lysosomal storage diseases
11/27/2013EP2666475A1 Therapeutic agent for alopecia
11/27/2013EP2666474A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013EP2666473A1 Peptides and related molecules that modulate nerve growth factor activity
11/27/2013EP2666472A2 Uses and compositions for treatment of psoriatic arthritis
11/27/2013EP2666467A1 Extract of aquatic animal cartilage
11/27/2013EP2666014A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
11/27/2013EP2665814A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
11/27/2013EP2665747A1 Methods for treating disorders that involve immunoglobulin a
11/27/2013EP2665742A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
11/27/2013EP2665521A2 Compositions and methods for treating cancer
11/27/2013EP2665490A1 Vaccines and compositions against streptococcus pneumoniae
11/27/2013EP2665489A1 Combination therapy for cancer
11/27/2013EP2665488A2 Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
11/27/2013EP2665487A1 Combination of acylated glucagon analogues with insulin analogues
11/27/2013EP2665486A1 Compositions and mehthods for modulating gamma-c-cytokine activity
11/27/2013EP2665485A1 Apolipoprotein aiv as an antidiabetic peptide
11/27/2013EP2665470A1 Glp-1 particles and compositions
11/27/2013EP2665469A1 Glp-1 compositions
11/27/2013CN103415621A Aldehyde-tagged immunoglobulin polypeptides and method of use thereof
11/27/2013CN103415532A Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
11/27/2013CN103415301A Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
11/27/2013CN103415300A N-terminal modified FGF21 compounds
11/27/2013CN103415297A A nutritional composition comprising fiber and probiotics for reducing stress-related intestinal symptoms
11/27/2013CN103415295A Fiber and probiotics for reducing intestinal symptoms related to stress
11/27/2013CN103415286A Compounds and methods for treating pain
11/27/2013CN103415281A Skin-beautifying agent
11/27/2013CN103409465A Preparation method and application of recombinant human leucocyte interleukin 27
11/27/2013CN103409435A Preparation and application of water stress protein gene of nostoc commune and recombinant proteins of gene
11/27/2013CN103409384A Prawn protein with antiviral activity and application of prawn protein
11/27/2013CN103409378A Preparation method and application of tyrosyl tRNA (transfer ribonucleic acid) synthetase mutant
11/27/2013CN103409359A Prokaryotic expression strain of TREM-1 extracellular domain, and application of prokaryotic expression strain in treating septicemia caused by streptococcus suis infection.
11/27/2013CN103408669A Fusion protein of GLP-1 analogue and preparation method and application thereof
11/27/2013CN103408655A Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan units
11/27/2013CN103408654A rTRAIL (TNT Related Apoptosis-Inducing Ligand) mutant-mPEG-MAL conjugate and application thereof
11/27/2013CN103408653A Preparation method and use of biomimetic anti-caries polypeptide
11/27/2013CN103408652A Novel anti-HBV endogenous protein HNF1alpha and application thereof
11/27/2013CN103408650A Cereus sinensis verrill soluble cell peptide CCT-I and separating and purifying method and application thereof
11/27/2013CN103408634A Horse placenta water-soluble protein extract, preparation method and application thereof
11/27/2013CN103405765A Yolk powder-aplysia evasion hormone compound preparation and preparation method thereof
11/27/2013CN103405757A Composition for health-care product, health-care product and using method thereof
11/27/2013CN103405756A Medicine composition-compound digestive enzyme capsule (II) and preparation method thereof
11/27/2013CN103405755A Pharmaceutical composition for treating primary osteoporosis
11/27/2013CN103405754A Solubilization technology for producing human fibrinogen
11/27/2013CN103405753A Stable exendin water injection medicine composition
11/27/2013CN103405752A Oral thymosin alpha1 solid lipid nanoparticle absorption preparation and preparing method thereof
11/27/2013CN103405751A Composition with cell repairing function and preparation method and application thereof
11/27/2013CN103405750A Application of erythropoietin in mice genetic deafness treatment drug preparation
11/27/2013CN103405749A Toad skin transgelin-2-containing anti-tumor traditional Chinese medicine preparation and use thereof
11/27/2013CN103405748A Brand-new two-layer polymer covered polypeptide controlled-release composition
11/27/2013CN103405747A Preparation method for alanyl-glutamine biological adhesive preparation as well as product and application of preparation
1 ... 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 ... 3163